| 摘要 |
Un compuesto seleccionado de: tetranitrato de {μ-(1,8,11,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(caproato-O)platino(II)]}; tetranitrato de {μ-(1,7,12,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(caproato-O)platino(II)]}; tetranitrato de {μ-(1,5,10,14-tetraazatetradecan-N1,N14)bis[trans-diamino(caproato-O)platino(II)]}; tetranitrato de {μ-(1,5,10-triazadecan-N1,N10)bis[trans-diamino(caproato-O)platino(II)]}; tetranitrato de {μ-(1,8,11,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(caprilato-O)platino(II)]}; tetranitrato de {μ-(1,7,12,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(caprilato-O)platino(II)]}; tetranitrato de {μ-(1,5,10,14-tetraazatetradecan-N1,N14)bis[trans-diamino(caprilato-O)platino(II)]}; tetranitrato de {μ-(1,5,10-triazadecan-N1,N10)bis[trans-diamino(caprilato-O)platino(II)]}; tetrabutirato de {μ-(1,7,12,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(butirato-O)platino(II)]}; tetrabutirato de {μ-(1,7,12,18-tetraazaoctadecan-N1,N18)bis[trans-diamino(butirato-O)platino(II)]}; tetrabutirato de {μ-(1,5,10,14-tetraazatetradecan-N1,N14)bis[trans-diamino(butirato-O)platino(II)]}; tetrabutirato de {μ-(1,5,10-triazadecan-N1,N10)bis[trans-diamino(butirato-O)platino(II)]}.
|
| 申请人 |
CELL THERAPEUTICS, INC. - SEDE SECONDARIA |
发明人 |
BERNAREGGI, ALBERTO;GRUGNI, MARIO;MARIOTTI, GIULIO;MENTA, ERNESTO;PARDI, GIANLUCA;PAVESI, PAOLO;PEZZONI, GABRIELLA;NICOLI, PAOLA;DE MUNARI, SERGIO |
